Education
About Us
Working with TipRanks
Follow Us
Si-Bone (SIBN)
:SIBN
SIBN Stock Chart & Stats
Day’s Range― - ―
52-Week Range$11.70 - $20.05
Previous CloseN/A
Volume50.81K
Average Volume (3M)437.01K
Market Cap
$708.37M
Enterprise Value$696.66M
Total Cash (Recent Filing)$144.41M
Total Debt (Recent Filing)$37.15M
Price to Earnings (P/E)―
Beta0.88
Next Earnings
Nov 10, 2025EPS Estimate
-0.17Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.14
Shares Outstanding43,140,938
10 Day Avg. Volume377,712
30 Day Avg. Volume437,010
Financial Highlights & Ratios
PEG Ratio0.56
Price to Book (P/B)3.48
Price to Sales (P/S)3.48
P/FCF Ratio-25.36
Enterprise Value/Market Cap0.98
Enterprise Value/Revenue3.94
Enterprise Value/Gross Profit4.98
Enterprise Value/Ebitda-37.13
Forecast
1Y Price Target
$23.42Price Target Upside41.17% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
Bulls Say, Bears Say
Bulls Say
Financial PerformanceSIBN's 2Q25 revenue beat consensus and management raised its 2025 revenue guidance.
Operational EfficiencySIBN delivered an impressive Q beating top- and bottom-line expectations, including a second consecutive quarter of adj. EBITDA positivity.
Product LaunchesSIBN is seeing growing engagement across its callpoints while the launches of its Granite 9.5 and more recently its TNT product continue to support momentum.
Bears Say
Market PenetrationSIBN estimates a combined TAM of nearly $4B, yet noted given its most recent guide currently only penetrates this TAM by ~5%, emphasizing the significant growth opportunity.
Revenue GuidanceManagement continues to take a prudent approach to guidance, which should allow for upside in the second half of 2025.
SeasonalitySIBN achieved adjusted EBITDA despite seasonality, suggesting operational efficiency.
SI-Bone News
SIBN FAQ
What was Si-Bone’s price range in the past 12 months?
Si-Bone lowest stock price was $11.70 and its highest was $20.05 in the past 12 months.
What is Si-Bone’s market cap?
Si-Bone’s market cap is $708.37M.
When is Si-Bone’s upcoming earnings report date?
Si-Bone’s upcoming earnings report date is Nov 10, 2025 which is in 73 days.
How were Si-Bone’s earnings last quarter?
Si-Bone released its earnings results on Aug 04, 2025. The company reported -$0.14 earnings per share for the quarter, beating the consensus estimate of -$0.183 by $0.043.
Is Si-Bone overvalued?
According to Wall Street analysts Si-Bone’s price is currently Undervalued.
Does Si-Bone pay dividends?
Si-Bone does not currently pay dividends.
What is Si-Bone’s EPS estimate?
Si-Bone’s EPS estimate is -0.17.
How many shares outstanding does Si-Bone have?
Si-Bone has 43,140,938 shares outstanding.
What happened to Si-Bone’s price movement after its last earnings report?
Si-Bone reported an EPS of -$0.14 in its last earnings report, beating expectations of -$0.183. Following the earnings report the stock price went down -10.615%.
Which hedge fund is a major shareholder of Si-Bone?
Currently, no hedge funds are holding shares in SIBN
SI-Bone Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$23.42 (41.17% Upside)
$23.42 (41.17% Upside)
Blogger Sentiment
Bullish
SIBN Sentiment 70%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 35.2K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $784.3K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
0.66%
12-Months-Change
Fundamentals
Return on Equity
-14.18%
Trailing 12-Months
Asset Growth
3.16%
Trailing 12-Months
Company Description
Si-Bone
SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; and iFuse-TORQ, a set of 3D-printed threaded implants designed to treat fractures of the pelvis and for minimally invasive sacroiliac joint fusion. It markets its products primarily with a direct sales force, as well as through distributors. The company was incorporated in 2008 and is headquartered in Santa Clara, California.
SIBN Company Deck
SIBN Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
SI-BONE's earnings call highlighted strong revenue growth, improved profitability, and successful market expansion, despite some regulatory delays in Europe and continued net losses. The positive performance significantly outweighs the challenges faced.View all SIBN earnings summariesSIBN Stock 12 Month Forecast
Average Price Target
$23.42
▲(41.17% Upside)
Technical Analysis
Ownership Overview
5.05% Insiders
29.86% Mutual Funds
39.39% Other Institutional Investors
15.63% Public Companies and
Individual Investors